Synergistic antifungal activity of the lipophilic fraction of Hypericum carinatum and fluconazole

Detalhes bibliográficos
Autor(a) principal: Meirelles,Gabriela C.
Data de Publicação: 2017
Outros Autores: Pippi,Bruna, Hatwig,Camila, Barros,Francisco M.C. de, Oliveira,Luis F.S. de, Poser,Gilsane L. von, Fuentefria,Alexandre M.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista Brasileira de Farmacognosia (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-695X2017000100118
Resumo: ABSTRACT Hypericum species, Hypericaceae, are recognized as a source of therapeutical agents. Purified fractions and isolated compounds have been shown antimicrobial activity. As the indiscriminate use of antifungals and the increase of infections caused by emerging species are leading to the search of new alternative treatments, the aim of this study was to continue the study with Hypericum carinatum Griseb. lipophilic fraction, rich in phloroglucinol derivatives, investigating the effect of its association with fluconazole against emerging yeasts (Candida krusei, C. famata, C. parapsilosis and Cryptococcus neoformans). The synergistic activity between H. carinatum lipophilic fraction and fluconazole was assessed by two methodologies for multiple dose–response analysis: checkerboard and isobologram. Regarding synergistic experiments, the effect of the association was higher than the effect of fluconazole alone against Candida krusei and C. famata isolates (MIC fluconazole decreased about eight and four folds, respectively), suggesting that, somehow, H. carinatum lipophilic fraction compounds are facilitating the action of this drug. On the other hand, when tested against Cryptococcus neoformans and C. parapsilosis, fluconazole showed better results than the association. Thus, against Candida krusei and C. famata, the lipophilic fraction of H. carinatum was able to reduce the MIC values of fluconazole and could be considered as a potential alternative to be used against emerging yeast species.
id SBFGNOSIA-1_635cb3a797541691ce882fdc133e3b76
oai_identifier_str oai:scielo:S0102-695X2017000100118
network_acronym_str SBFGNOSIA-1
network_name_str Revista Brasileira de Farmacognosia (Online)
repository_id_str
spelling Synergistic antifungal activity of the lipophilic fraction of Hypericum carinatum and fluconazoleCandidaCheckerboardFluconazoleHypericum carinatumIsobologramSynergistic activityABSTRACT Hypericum species, Hypericaceae, are recognized as a source of therapeutical agents. Purified fractions and isolated compounds have been shown antimicrobial activity. As the indiscriminate use of antifungals and the increase of infections caused by emerging species are leading to the search of new alternative treatments, the aim of this study was to continue the study with Hypericum carinatum Griseb. lipophilic fraction, rich in phloroglucinol derivatives, investigating the effect of its association with fluconazole against emerging yeasts (Candida krusei, C. famata, C. parapsilosis and Cryptococcus neoformans). The synergistic activity between H. carinatum lipophilic fraction and fluconazole was assessed by two methodologies for multiple dose–response analysis: checkerboard and isobologram. Regarding synergistic experiments, the effect of the association was higher than the effect of fluconazole alone against Candida krusei and C. famata isolates (MIC fluconazole decreased about eight and four folds, respectively), suggesting that, somehow, H. carinatum lipophilic fraction compounds are facilitating the action of this drug. On the other hand, when tested against Cryptococcus neoformans and C. parapsilosis, fluconazole showed better results than the association. Thus, against Candida krusei and C. famata, the lipophilic fraction of H. carinatum was able to reduce the MIC values of fluconazole and could be considered as a potential alternative to be used against emerging yeast species.Sociedade Brasileira de Farmacognosia2017-02-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-695X2017000100118Revista Brasileira de Farmacognosia v.27 n.1 2017reponame:Revista Brasileira de Farmacognosia (Online)instname:Sociedade Brasileira de Farmacognosia (SBFgnosia)instacron:SBFGNOSIA10.1016/j.bjp.2016.08.001info:eu-repo/semantics/openAccessMeirelles,Gabriela C.Pippi,BrunaHatwig,CamilaBarros,Francisco M.C. deOliveira,Luis F.S. dePoser,Gilsane L. vonFuentefria,Alexandre M.eng2017-01-10T00:00:00Zoai:scielo:S0102-695X2017000100118Revistahttp://www.sbfgnosia.org.br/revista/https://old.scielo.br/oai/scielo-oai.phprbgnosia@ltf.ufpb.br1981-528X0102-695Xopendoar:2017-01-10T00:00Revista Brasileira de Farmacognosia (Online) - Sociedade Brasileira de Farmacognosia (SBFgnosia)false
dc.title.none.fl_str_mv Synergistic antifungal activity of the lipophilic fraction of Hypericum carinatum and fluconazole
title Synergistic antifungal activity of the lipophilic fraction of Hypericum carinatum and fluconazole
spellingShingle Synergistic antifungal activity of the lipophilic fraction of Hypericum carinatum and fluconazole
Meirelles,Gabriela C.
Candida
Checkerboard
Fluconazole
Hypericum carinatum
Isobologram
Synergistic activity
title_short Synergistic antifungal activity of the lipophilic fraction of Hypericum carinatum and fluconazole
title_full Synergistic antifungal activity of the lipophilic fraction of Hypericum carinatum and fluconazole
title_fullStr Synergistic antifungal activity of the lipophilic fraction of Hypericum carinatum and fluconazole
title_full_unstemmed Synergistic antifungal activity of the lipophilic fraction of Hypericum carinatum and fluconazole
title_sort Synergistic antifungal activity of the lipophilic fraction of Hypericum carinatum and fluconazole
author Meirelles,Gabriela C.
author_facet Meirelles,Gabriela C.
Pippi,Bruna
Hatwig,Camila
Barros,Francisco M.C. de
Oliveira,Luis F.S. de
Poser,Gilsane L. von
Fuentefria,Alexandre M.
author_role author
author2 Pippi,Bruna
Hatwig,Camila
Barros,Francisco M.C. de
Oliveira,Luis F.S. de
Poser,Gilsane L. von
Fuentefria,Alexandre M.
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Meirelles,Gabriela C.
Pippi,Bruna
Hatwig,Camila
Barros,Francisco M.C. de
Oliveira,Luis F.S. de
Poser,Gilsane L. von
Fuentefria,Alexandre M.
dc.subject.por.fl_str_mv Candida
Checkerboard
Fluconazole
Hypericum carinatum
Isobologram
Synergistic activity
topic Candida
Checkerboard
Fluconazole
Hypericum carinatum
Isobologram
Synergistic activity
description ABSTRACT Hypericum species, Hypericaceae, are recognized as a source of therapeutical agents. Purified fractions and isolated compounds have been shown antimicrobial activity. As the indiscriminate use of antifungals and the increase of infections caused by emerging species are leading to the search of new alternative treatments, the aim of this study was to continue the study with Hypericum carinatum Griseb. lipophilic fraction, rich in phloroglucinol derivatives, investigating the effect of its association with fluconazole against emerging yeasts (Candida krusei, C. famata, C. parapsilosis and Cryptococcus neoformans). The synergistic activity between H. carinatum lipophilic fraction and fluconazole was assessed by two methodologies for multiple dose–response analysis: checkerboard and isobologram. Regarding synergistic experiments, the effect of the association was higher than the effect of fluconazole alone against Candida krusei and C. famata isolates (MIC fluconazole decreased about eight and four folds, respectively), suggesting that, somehow, H. carinatum lipophilic fraction compounds are facilitating the action of this drug. On the other hand, when tested against Cryptococcus neoformans and C. parapsilosis, fluconazole showed better results than the association. Thus, against Candida krusei and C. famata, the lipophilic fraction of H. carinatum was able to reduce the MIC values of fluconazole and could be considered as a potential alternative to be used against emerging yeast species.
publishDate 2017
dc.date.none.fl_str_mv 2017-02-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-695X2017000100118
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-695X2017000100118
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1016/j.bjp.2016.08.001
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Farmacognosia
publisher.none.fl_str_mv Sociedade Brasileira de Farmacognosia
dc.source.none.fl_str_mv Revista Brasileira de Farmacognosia v.27 n.1 2017
reponame:Revista Brasileira de Farmacognosia (Online)
instname:Sociedade Brasileira de Farmacognosia (SBFgnosia)
instacron:SBFGNOSIA
instname_str Sociedade Brasileira de Farmacognosia (SBFgnosia)
instacron_str SBFGNOSIA
institution SBFGNOSIA
reponame_str Revista Brasileira de Farmacognosia (Online)
collection Revista Brasileira de Farmacognosia (Online)
repository.name.fl_str_mv Revista Brasileira de Farmacognosia (Online) - Sociedade Brasileira de Farmacognosia (SBFgnosia)
repository.mail.fl_str_mv rbgnosia@ltf.ufpb.br
_version_ 1752122470168526848